US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

MAIA Biotechnology Inc.

1.35

-0.0400-2.88%

Post-market: 1.350.0006+0.04%19:30 EDT

Volume:228.00K

Turnover:307.37K

Market Cap:81.91M

PE:-2.22

High:1.40

Open:1.40

Low:1.33

Close:1.39

52wk High:3.19

52wk Low:0.8700

Shares:60.67M

Float Shares:55.61M

Volume Ratio:0.79

T/O Rate:0.41%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.6085

EPS(LYR):-0.7000

ROE:-218.68%

ROA:-92.10%

PB:3.96

PE(LYR):-1.93

Loading ...

Overview Company News Filings

Maia Biotechnology Director Ramiro Guerrero Reports Purchase of 11,899 Common Shares for $16,301.63

MAIA Biotechnology files $150M mixed securities shelf

MAIA Biotechnology Q2 EPS $(0.13) Misses $(0.11) Estimate

Benzinga Earnings

Maia Biotech Q2 FY26 Net Loss Widens 49% to $7.94 Million

Noble Financial Sticks to Their Buy Rating for MAIA Biotechnology, Inc. (MAIA)

Maia Biotechnology Says Ateganosine Plus Cemiplimab Outperforms Standard Chemotherapy Dcr in 3l Nsclc

MAIA Biotechnology reports efficacy data from Phase 2 THIO-101 Part C expansion

Maia Biotech Reports 90.5% Disease Control Rate in Phase 2 Third-line NSCLC Trial Expansion

Maia Biotechnology - Ateganosine Plus Cemiplimab Shows Acceptable Safety Profile in Heavily Pre-treated Patients

THOMSON REUTERS

Maia Biotechnology Reports Strong Initial Efficacy Data in Third-line Non-small Cell Lung Cancer from Phase 2 Thio-101 Part C Expansion Trial

THOMSON REUTERS

Maia Biotechnology - Thio-101 Part C Shows 90.5% Disease Control Rate in 3L Nsclc

THOMSON REUTERS

Maia Biotechnology - Ateganosine Plus Cemiplimab Outperforms Standard Chemotherapy Dcr in 3L Nsclc

THOMSON REUTERS

Maia Biotechnology Completes International Enrollment in Part C of Phase 2 Thio-101 Expansion Trial in Third-line Non-small Cell Lung Cancer

THOMSON REUTERS

MAIA Biotechnology Completes International Enrollment in Part C of Phase 2 THIO-101 Expansion Trial in Third-Line Non-Small Cell Lung Cancer

Maia Biotech opens enrollment at Emory Winship for Phase 2 ateganosine NSCLC trial

Maia Biotechnology Opens Enrollment for Phase 2 Expansion Trial of Novel Telomere-Targeting Agent at Winship Cancer Institute of Emory University

THOMSON REUTERS

Compugen to Unveil Latest Data from MAIA Ovarian Cancer Drug Trial at European Conference

Maia Biotech opens enrollment at second US site for Phase 2 THIO-101 lung cancer trial expansion

Maia Biotechnology Activates and Opens Enrollment at Second U.S. Clinical Site for International Phase 2 Thio-101 Expansion Trial

THOMSON REUTERS

MAIA Biotechnology Activates and Opens Enrollment at Second U.S. Clinical Site for International Phase 2 THIO-101 Expansion Trial

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/MAIA/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"MAIA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MAIA\",,,,,undefined,":{"symbol":"MAIA","market":"US","secType":"STK","nameCN":"MAIA Biotechnology Inc.","latestPrice":1.35,"timestamp":1787601600000,"preClose":1.39,"halted":0,"volume":227998,"hourTrading":{"tag":"盘后","latestPrice":1.3506,"preClose":1.35,"latestTime":"19:30 EDT","volume":2596,"amount":3522.1493,"timestamp":1787614203427,"change":0.0006,"changeRate":0.000444,"amplitude":0.014815},"delay":0,"changeRate":-0.028776978417266053,"floatShares":55605100,"shares":60671491,"eps":-0.608478,"marketStatus":"Not Yet Opened","change":-0.04,"latestTime":"08-24 16:00:00 EDT","open":1.4,"high":1.4,"low":1.325,"amount":307372.1293296,"amplitude":0.053957,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.608478,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787644800000},"marketStatusCode":0,"adr":0,"listingDate":1659067200000,"exchange":"AMEX","adjPreClose":1.39,"preHourTrading":{"tag":"盘前","latestPrice":1.39,"preClose":1.39,"latestTime":"08:59 EDT","volume":2369,"amount":3340.3878397000003,"timestamp":1787576362359,"change":0,"changeRate":0,"amplitude":0.040863},"postHourTrading":{"tag":"盘后","latestPrice":1.3506,"preClose":1.35,"latestTime":"19:30 EDT","volume":2596,"amount":3522.1493,"timestamp":1787614203427,"change":0.0006,"changeRate":0.000444,"amplitude":0.014815},"volumeRatio":0.79},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MAIA\",,,,,undefined,":{"symbol":"MAIA","floatShares":55605100,"roa":"-92.10%","roe":"-218.68%","lyrEps":-0.7,"volumeRatio":0.79,"shares":60671491,"dividePrice":0,"high":1.4,"amplitude":0.053957,"preClose":1.39,"low":1.325,"week52Low":0.87,"pbRate":"3.96","week52High":3.19,"institutionHeld":0,"latestPrice":1.35,"eps":-0.608478,"divideRate":0,"volume":227998,"delay":0,"ttmEps":-0.608478,"open":1.4,"prevYearClose":1.53,"prevWeekClose":1.39,"prevMonthClose":1.25,"prevQuarterClose":1.44,"fiveDayClose":1.39,"twentyDayClose":1.28,"sixtyDayClose":1.29},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MAIA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-10","symbol":"MAIA","fiscalQuarterEnding":"2026/06","expectedEps":-0.11,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1786334400000,"reportTimeType":"pre","actualEps":-0.13},{"market":"US","date":"2026-05-11","symbol":"MAIA","fiscalQuarterEnding":"2026/03","expectedEps":-0.18,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1778472000000,"reportTimeType":"pre","actualEps":-0.14},{"market":"US","date":"2026-03-23","symbol":"MAIA","fiscalQuarterEnding":"2025/12","expectedEps":-0.13,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1774238400000,"reportTimeType":"pre","actualEps":-0.08},{"market":"US","date":"2025-11-07","symbol":"MAIA","fiscalQuarterEnding":"2025/09","expectedEps":-0.19,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1762491600000,"reportTimeType":"post","actualEps":-0.27},{"market":"US","date":"2025-08-11","symbol":"MAIA","fiscalQuarterEnding":"2025/06","expectedEps":-0.24,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1754884800000,"reportTimeType":"pre","actualEps":-0.18}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MAIA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MAIA\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":1,"updateTime":1677211200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/MAIA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"MAIA","date":"2026-08-21","current":-2.21865,"percent":0.259036,"low":-5.555213,"twenty":-3.250637,"median":-2.503408,"eighty":-1.825742,"high":-0.77644,"avg":-2.512333,"sd":0.787481,"marketCap":83939664},"quantilePoints":[{"date":"2022-07-29","current":-4.130799,"twenty":-3.74477,"median":-3.33193,"eighty":-3.032982,"marketCap":61688243},{"date":"2022-08-05","current":-3.418592,"twenty":-4.327368,"median":-3.717719,"eighty":-3.321732,"marketCap":51052339},{"date":"2022-08-12","current":-3.539667,"twenty":-3.942776,"median":-3.513542,"eighty":-3.113768,"marketCap":52860442},{"date":"2022-08-19","current":-2.813217,"twenty":-3.757603,"median":-3.418592,"eighty":-3.057447,"marketCap":42011820},{"date":"2022-08-26","current":-2.813564,"twenty":-3.645074,"median":-3.16932,"eighty":-3.031815,"marketCap":41665794},{"date":"2022-09-02","current":-3.160645,"twenty":-3.562458,"median":-3.149236,"eighty":-2.973073,"marketCap":46805669},{"date":"2022-09-09","current":-3.035105,"twenty":-3.531121,"median":-3.079413,"eighty":-2.987843,"marketCap":44946565},{"date":"2022-09-16","current":-2.628947,"twenty":-3.505948,"median":-3.054305,"eighty":-2.874118,"marketCap":38931818},{"date":"2022-09-23","current":-2.400022,"twenty":-3.459888,"median":-3.035105,"eighty":-2.808995,"marketCap":35541688},{"date":"2022-09-30","current":-2.436946,"twenty":-3.337714,"median":-3.018069,"eighty":-2.628947,"marketCap":36088483},{"date":"2022-10-07","current":-2.481254,"twenty":-3.200415,"median":-2.976027,"eighty":-2.544762,"marketCap":36744637},{"date":"2022-10-14","current":-2.429561,"twenty":-3.170744,"median":-2.946489,"eighty":-2.506362,"marketCap":35979124},{"date":"2022-10-21","current":-2.326175,"twenty":-3.161577,"median":-2.817793,"eighty":-2.443001,"marketCap":34448097},{"date":"2022-10-28","current":-2.392637,"twenty":-3.156081,"median":-2.809698,"eighty":-2.436946,"marketCap":35432328},{"date":"2022-11-04","current":-2.673255,"twenty":-3.130168,"median":-2.80618,"eighty":-2.436946,"marketCap":39587972},{"date":"2022-11-11","current":-2.861595,"twenty":-3.092705,"median":-2.80618,"eighty":-2.443001,"marketCap":41539705},{"date":"2022-11-18","current":-2.59391,"twenty":-3.074979,"median":-2.80618,"eighty":-2.45489,"marketCap":37653909},{"date":"2022-11-25","current":-2.639153,"twenty":-3.06641,"median":-2.741401,"eighty":-2.463531,"marketCap":38310664},{"date":"2022-12-02","current":-2.782421,"twenty":-3.056964,"median":-2.74683,"eighty":-2.481254,"marketCap":40390385},{"date":"2022-12-09","current":-2.639153,"twenty":-3.048124,"median":-2.714557,"eighty":-2.485685,"marketCap":38310664},{"date":"2022-12-16","current":-2.571289,"twenty":-3.039919,"median":-2.704828,"eighty":-2.491357,"marketCap":37325532},{"date":"2022-12-23","current":-2.526046,"twenty":-3.035105,"median":-2.684395,"eighty":-2.489852,"marketCap":36668778},{"date":"2022-12-30","current":-2.646693,"twenty":-3.035105,"median":-2.669314,"eighty":-2.488344,"marketCap":38420123},{"date":"2023-01-06","current":-2.646693,"twenty":-3.028524,"median":-2.669314,"eighty":-2.494376,"marketCap":38420123},{"date":"2023-01-13","current":-3.008634,"twenty":-3.036309,"median":-2.678825,"eighty":-2.495884,"marketCap":43674156},{"date":"2023-01-20","current":-3.649345,"twenty":-3.053419,"median":-2.693672,"eighty":-2.500398,"marketCap":52974891},{"date":"2023-01-27","current":-3.381885,"twenty":-3.088275,"median":-2.710179,"eighty":-2.507838,"marketCap":49092379},{"date":"2023-02-03","current":-3.566626,"twenty":-3.137263,"median":-2.727137,"eighty":-2.510896,"marketCap":51774125},{"date":"2023-02-10","current":-3.332873,"twenty":-3.167896,"median":-2.752259,"eighty":-2.519723,"marketCap":48380895},{"date":"2023-02-17","current":-3.415817,"twenty":-3.245403,"median":-2.79807,"eighty":-2.525852,"marketCap":49584945},{"date":"2023-02-24","current":-3.566626,"twenty":-3.3193,"median":-2.80618,"eighty":-2.527554,"marketCap":51774125},{"date":"2023-03-03","current":-3.4686,"twenty":-3.350216,"median":-2.813564,"eighty":-2.531068,"marketCap":50351158},{"date":"2023-03-10","current":-3.016174,"twenty":-3.350216,"median":-2.827663,"eighty":-2.542251,"marketCap":43783616},{"date":"2023-03-17","current":-2.473263,"twenty":-3.346445,"median":-2.827663,"eighty":-2.542251,"marketCap":35902565},{"date":"2023-03-24","current":-2.399976,"twenty":-3.342675,"median":-2.81339,"eighty":-2.516804,"marketCap":38927270},{"date":"2023-03-31","current":-2.345739,"twenty":-3.337397,"median":-2.80618,"eighty":-2.495884,"marketCap":38047557},{"date":"2023-04-06","current":-2.284723,"twenty":-3.326087,"median":-2.805042,"eighty":-2.481254,"marketCap":37057881},{"date":"2023-04-14","current":-2.447433,"twenty":-3.292155,"median":-2.76734,"eighty":-2.461933,"marketCap":39697018},{"date":"2023-04-21","current":-2.393197,"twenty":-3.261993,"median":-2.739718,"eighty":-2.455007,"marketCap":38817306},{"date":"2023-04-28","current":-1.958672,"twenty":-3.24842,"median":-2.712368,"eighty":-2.44201,"marketCap":31769373},{"date":"2023-05-05","current":-2.318612,"twenty":-3.242387,"median":-2.695409,"eighty":-2.436946,"marketCap":37607553},{"date":"2023-05-12","current":-2.109365,"twenty":-3.242387,"median":-2.678825,"eighty":-2.414792,"marketCap":34746108},{"date":"2023-05-19","current":-1.988788,"twenty":-3.237189,"median":-2.669314,"eighty":-2.399985,"marketCap":33656034},{"date":"2023-05-26","current":-1.827752,"twenty":-3.208406,"median":-2.654233,"eighty":-2.392749,"marketCap":30930849},{"date":"2023-06-02","current":-2.069306,"twenty":-3.176442,"median":-2.646693,"eighty":-2.379637,"marketCap":35018627},{"date":"2023-06-09","current":-1.988788,"twenty":-3.162198,"median":-2.639153,"eighty":-2.33896,"marketCap":33656034},{"date":"2023-06-16","current":-1.851908,"twenty":-3.160645,"median":-2.635382,"eighty":-2.318791,"marketCap":31339627},{"date":"2023-06-23","current":-1.763338,"twenty":-3.153651,"median":-2.628947,"eighty":-2.307373,"marketCap":29840775},{"date":"2023-06-30","current":-1.731131,"twenty":-3.150302,"median":-2.609948,"eighty":-2.28744,"marketCap":29295738},{"date":"2023-07-07","current":-1.779442,"twenty":-3.141254,"median":-2.59768,"eighty":-2.242232,"marketCap":30113294},{"date":"2023-07-14","current":-1.755286,"twenty":-3.123249,"median":-2.586369,"eighty":-2.20532,"marketCap":29704516},{"date":"2023-07-21","current":-1.851908,"twenty":-3.111184,"median":-2.578041,"eighty":-2.067676,"marketCap":31339627},{"date":"2023-07-28","current":-1.859959,"twenty":-3.104623,"median":-2.56987,"eighty":-2.008112,"marketCap":31475886},{"date":"2023-08-04","current":-1.715028,"twenty":-3.097572,"median":-2.563748,"eighty":-1.974295,"marketCap":29023220},{"date":"2023-08-11","current":-1.557401,"twenty":-3.086713,"median":-2.556208,"eighty":-1.943698,"marketCap":28252239},{"date":"2023-08-18","current":-1.369309,"twenty":-3.075231,"median":-2.531381,"eighty":-1.90827,"marketCap":24840133},{"date":"2023-08-25","current":-1.437022,"twenty":-3.068706,"median":-2.525562,"eighty":-1.887815,"marketCap":26068491},{"date":"2023-09-01","current":-1.316644,"twenty":-3.064492,"median":-2.5071,"eighty":-1.866401,"marketCap":23884743},{"date":"2023-09-08","current":-1.32732,"twenty":-3.056964,"median":-2.495884,"eighty":-1.852819,"marketCap":24078428},{"date":"2023-09-15","current":-1.319779,"twenty":-3.048124,"median":-2.488344,"eighty":-1.851908,"marketCap":23941618},{"date":"2023-09-22","current":-1.161405,"twenty":-3.039919,"median":-2.477259,"eighty":-1.830989,"marketCap":21068624},{"date":"2023-09-29","current":-1.357487,"twenty":-3.035105,"median":-2.458182,"eighty":-1.797155,"marketCap":24625665},{"date":"2023-10-06","current":-1.89294,"twenty":-3.03346,"median":-2.451363,"eighty":-1.795545,"marketCap":34339121},{"date":"2023-10-13","current":-1.696859,"twenty":-3.026246,"median":-2.440654,"eighty":-1.781052,"marketCap":30782081},{"date":"2023-10-20","current":-1.772274,"twenty":-3.023715,"median":-2.436946,"eighty":-1.772274,"marketCap":32150173},{"date":"2023-10-27","current":-1.402736,"twenty":-3.020699,"median":-2.436946,"eighty":-1.772274,"marketCap":25446520},{"date":"2023-11-03","current":-1.538485,"twenty":-3.016174,"median":-2.424938,"eighty":-1.763338,"marketCap":27909087},{"date":"2023-11-10","current":-1.563529,"twenty":-3.013408,"median":-2.414792,"eighty":-1.758507,"marketCap":28319514},{"date":"2023-11-17","current":-1.098625,"twenty":-3.009008,"median":-2.400022,"eighty":-1.737573,"marketCap":19898915},{"date":"2023-11-24","current":-1.0945,"twenty":-3.00802,"median":-2.398918,"eighty":-1.715028,"marketCap":19824192},{"date":"2023-12-01","current":-0.93547,"twenty":-3.003917,"median":-2.393197,"eighty":-1.697272,"marketCap":16943754},{"date":"2023-12-08","current":-0.853009,"twenty":-2.993064,"median":-2.385536,"eighty":-1.662077,"marketCap":15450179},{"date":"2023-12-15","current":-0.830323,"twenty":-2.97455,"median":-2.366078,"eighty":-1.603306,"marketCap":15039276},{"date":"2023-12-22","current":-0.963534,"twenty":-2.967166,"median":-2.34235,"eighty":-1.566156,"marketCap":17452066},{"date":"2023-12-29","current":-1.159983,"twenty":-2.962735,"median":-2.332248,"eighty":-1.560368,"marketCap":21010254},{"date":"2024-01-05","current":-1.113209,"twenty":-2.959095,"median":-2.329178,"eighty":-1.540033,"marketCap":20163067},{"date":"2024-01-12","current":-1.319013,"twenty":-2.946198,"median":-2.318612,"eighty":-1.505189,"marketCap":23890693},{"date":"2024-01-19","current":-1.178692,"twenty":-2.917694,"median":-2.307373,"eighty":-1.461419,"marketCap":21349130},{"date":"2024-01-26","current":-1.262884,"twenty":-2.860841,"median":-2.292944,"eighty":-1.43018,"marketCap":22874067},{"date":"2024-02-02","current":-1.449978,"twenty":-2.853404,"median":-2.250825,"eighty":-1.422652,"marketCap":26262818},{"date":"2024-02-09","current":-1.337722,"twenty":-2.835718,"median":-2.238161,"eighty":-1.406928,"marketCap":24229568},{"date":"2024-02-16","current":-1.472372,"twenty":-2.835615,"median":-2.225173,"eighty":-1.406928,"marketCap":26668418},{"date":"2024-02-23","current":-1.37859,"twenty":-2.835204,"median":-2.173979,"eighty":-1.403205,"marketCap":24969793},{"date":"2024-03-01","current":-1.228539,"twenty":-2.828334,"median":-2.067947,"eighty":-1.384495,"marketCap":22251992},{"date":"2024-03-08","current":-1.312943,"twenty":-2.827663,"median":-2.013443,"eighty":-1.37859,"marketCap":23780755},{"date":"2024-03-15","current":-1.228539,"twenty":-2.827663,"median":-1.99684,"eighty":-1.369309,"marketCap":22251992},{"date":"2024-03-22","current":-1.819364,"twenty":-2.817793,"median":-1.988788,"eighty":-1.369309,"marketCap":32953332},{"date":"2024-03-28","current":-2.508838,"twenty":-2.81441,"median":-1.988788,"eighty":-1.373975,"marketCap":49607008},{"date":"2024-04-05","current":-2.225582,"twenty":-2.813286,"median":-2.013193,"eighty":-1.375141,"marketCap":44006217},{"date":"2024-04-12","current":-2.458256,"twenty":-2.807587,"median":-2.066589,"eighty":-1.376495,"marketCap":48606867},{"date":"2024-04-19","current":-2.040149,"twenty":-2.80618,"median":-2.065155,"eighty":-1.378239,"marketCap":40339679},{"date":"2024-04-26","current":-2.789592,"twenty":-2.80618,"median":-2.083954,"eighty":-1.37859,"marketCap":55158336},{"date":"2024-05-03","current":-3.278811,"twenty":-2.81441,"median":-2.154257,"eighty":-1.383204,"marketCap":64831627},{"date":"2024-05-10","current":-3.008179,"twenty":-2.829708,"median":-2.225173,"eighty":-1.384467,"marketCap":59480445},{"date":"2024-05-17","current":-2.706777,"twenty":-2.835307,"median":-2.225893,"eighty":-1.384495,"marketCap":64214183},{"date":"2024-05-24","current":-3.507054,"twenty":-2.863599,"median":-2.234604,"eighty":-1.387273,"marketCap":83199537},{"date":"2024-05-31","current":-4.040936,"twenty":-2.958014,"median":-2.241717,"eighty":-1.392304,"marketCap":95865084},{"date":"2024-06-07","current":-3.056015,"twenty":-2.984545,"median":-2.267774,"eighty":-1.39972,"marketCap":72499334},{"date":"2024-06-14","current":-3.488644,"twenty":-3.008452,"median":-2.292944,"eighty":-1.402924,"marketCap":82762794},{"date":"2024-06-21","current":-3.157269,"twenty":-3.016174,"median":-2.307373,"eighty":-1.403205,"marketCap":74901421},{"date":"2024-06-28","current":-3.06522,"twenty":-3.024981,"median":-2.311144,"eighty":-1.403205,"marketCap":72717706},{"date":"2024-07-05","current":-3.12045,"twenty":-3.037686,"median":-2.318701,"eighty":-1.404613,"marketCap":74027935},{"date":"2024-07-12","current":-3.516259,"twenty":-3.053559,"median":-2.33218,"eighty":-1.406806,"marketCap":83417909},{"date":"2024-07-15","current":-3.359776,"twenty":-3.057103,"median":-2.332214,"eighty":-1.406847,"marketCap":79705593},{"date":"2024-08-02","current":-2.853508,"twenty":-3.056559,"median":-2.332248,"eighty":-1.406887,"marketCap":67695161},{"date":"2024-08-09","current":-2.448494,"twenty":-3.051102,"median":-2.34235,"eighty":-1.406928,"marketCap":58086816},{"date":"2024-08-16","current":-2.426555,"twenty":-3.049827,"median":-2.33896,"eighty":-1.409608,"marketCap":68135554},{"date":"2024-08-23","current":-2.554268,"twenty":-3.042861,"median":-2.346358,"eighty":-1.412104,"marketCap":71721636},{"date":"2024-08-30","current":-2.383983,"twenty":-3.039749,"median":-2.352417,"eighty":-1.420092,"marketCap":66940193},{"date":"2024-09-06","current":-2.681981,"twenty":-3.036825,"median":-2.358441,"eighty":-1.424007,"marketCap":75307717},{"date":"2024-09-13","current":-2.767124,"twenty":-3.035105,"median":-2.377326,"eighty":-1.427844,"marketCap":77698439},{"date":"2024-09-20","current":-2.426555,"twenty":-3.030169,"median":-2.383983,"eighty":-1.429499,"marketCap":68135554},{"date":"2024-09-27","current":-2.222213,"twenty":-3.024981,"median":-2.383983,"eighty":-1.430561,"marketCap":62397823},{"date":"2024-10-04","current":-2.213699,"twenty":-3.01919,"median":-2.379637,"eighty":-1.432249,"marketCap":62158751},{"date":"2024-10-11","current":-2.247756,"twenty":-3.016174,"median":-2.371702,"eighty":-1.435374,"marketCap":63115039},{"date":"2024-10-18","current":-2.141328,"twenty":-3.012024,"median":-2.358441,"eighty":-1.437022,"marketCap":60126638},{"date":"2024-10-25","current":-2.188156,"twenty":-3.008884,"median":-2.346358,"eighty":-1.441989,"marketCap":61441534},{"date":"2024-10-31","current":-2.389927,"twenty":-3.008452,"median":-2.345739,"eighty":-1.447172,"marketCap":67107079},{"date":"2024-11-08","current":-2.83377,"twenty":-3.007134,"median":-2.34725,"eighty":-1.453828,"marketCap":79569822},{"date":"2024-11-15","current":-1.968024,"twenty":-3.002269,"median":-2.346358,"eighty":-1.460958,"marketCap":51049313},{"date":"2024-11-22","current":-2.076001,"twenty":-2.988805,"median":-2.341497,"eighty":-1.465271,"marketCap":53850185},{"date":"2024-11-29","current":-2.158258,"twenty":-2.975456,"median":-2.338036,"eighty":-1.469425,"marketCap":55983872},{"date":"2024-12-06","current":-1.933643,"twenty":-2.972266,"median":-2.332214,"eighty":-1.472826,"marketCap":50157496},{"date":"2024-12-13","current":-1.96294,"twenty":-2.967505,"median":-2.321643,"eighty":-1.479063,"marketCap":50917458},{"date":"2024-12-20","current":-1.992238,"twenty":-2.962612,"median":-2.316763,"eighty":-1.498022,"marketCap":51677420},{"date":"2024-12-27","current":-1.992238,"twenty":-2.961258,"median":-2.307373,"eighty":-1.503103,"marketCap":51677420},{"date":"2025-01-03","current":-2.041067,"twenty":-2.956932,"median":-2.307355,"eighty":-1.507276,"marketCap":52944024},{"date":"2025-01-10","current":-2.080131,"twenty":-2.941372,"median":-2.303098,"eighty":-1.515197,"marketCap":53957306},{"date":"2025-01-17","current":-1.972706,"twenty":-2.899372,"median":-2.296637,"eighty":-1.531004,"marketCap":51170779},{"date":"2025-01-24","current":-1.933643,"twenty":-2.87533,"median":-2.284723,"eighty":-1.538485,"marketCap":50157496},{"date":"2025-01-31","current":-1.875661,"twenty":-2.867606,"median":-2.264784,"eighty":-1.540033,"marketCap":48653485},{"date":"2025-02-07","current":-1.996671,"twenty":-2.860087,"median":-2.25627,"eighty":-1.544371,"marketCap":51792420},{"date":"2025-02-14","current":-1.885745,"twenty":-2.856098,"median":-2.247756,"eighty":-1.551399,"marketCap":48915063},{"date":"2025-02-21","current":-1.915998,"twenty":-2.84995,"median":-2.243914,"eighty":-1.558143,"marketCap":49699797},{"date":"2025-02-28","current":-1.986587,"twenty":-2.835718,"median":-2.237919,"eighty":-1.561594,"marketCap":51530842},{"date":"2025-03-07","current":-1.854501,"twenty":-2.835615,"median":-2.232622,"eighty":-1.563808,"marketCap":48104595},{"date":"2025-03-14","current":-1.703553,"twenty":-2.834917,"median":-2.225582,"eighty":-1.566156,"marketCap":44189105},{"date":"2025-03-21","current":-1.897628,"twenty":-2.832683,"median":-2.223693,"eighty":-1.572339,"marketCap":49223306},{"date":"2025-03-28","current":-2.073878,"twenty":-2.8282,"median":-2.216853,"eighty":-1.577368,"marketCap":48227321},{"date":"2025-04-04","current":-2.022985,"twenty":-2.827663,"median":-2.202461,"eighty":-1.578876,"marketCap":47043829},{"date":"2025-04-11","current":-1.857584,"twenty":-2.825689,"median":-2.188156,"eighty":-1.588437,"marketCap":43197478},{"date":"2025-04-17","current":-1.959369,"twenty":-2.817793,"median":-2.17779,"eighty":-1.602543,"marketCap":45564463},{"date":"2025-04-25","current":-2.671867,"twenty":-2.813564,"median":-2.188156,"eighty":-1.606359,"marketCap":62133359},{"date":"2025-05-02","current":-3.155348,"twenty":-2.827663,"median":-2.19667,"eighty":-1.631509,"marketCap":73376538},{"date":"2025-05-09","current":-2.493743,"twenty":-2.817793,"median":-2.215276,"eighty":-1.659151,"marketCap":57991135},{"date":"2025-05-16","current":-2.722426,"twenty":-2.827663,"median":-2.222213,"eighty":-1.659151,"marketCap":53643944},{"date":"2025-05-23","current":-2.753188,"twenty":-2.817793,"median":-2.225582,"eighty":-1.671207,"marketCap":54250090},{"date":"2025-05-30","current":-2.78395,"twenty":-2.815328,"median":-2.228422,"eighty":-1.673266,"marketCap":54856236},{"date":"2025-06-06","current":-2.999283,"twenty":-2.815328,"median":-2.236289,"eighty":-1.687454,"marketCap":59099260},{"date":"2025-06-13","current":-2.691665,"twenty":-2.813794,"median":-2.242361,"eighty":-1.695662,"marketCap":53037797},{"date":"2025-06-20","current":-2.768569,"twenty":-2.813356,"median":-2.24629,"eighty":-1.696859,"marketCap":54553163},{"date":"2025-06-27","current":-2.676284,"twenty":-2.813356,"median":-2.250825,"eighty":-1.698098,"marketCap":52734724},{"date":"2025-07-03","current":-2.845474,"twenty":-2.814253,"median":-2.264726,"eighty":-1.69915,"marketCap":56068529},{"date":"2025-07-11","current":-2.968522,"twenty":-2.827663,"median":-2.264784,"eighty":-1.701114,"marketCap":58493114},{"date":"2025-07-18","current":-2.737807,"twenty":-2.823715,"median":-2.284723,"eighty":-1.703553,"marketCap":53947017},{"date":"2025-07-25","current":-2.630141,"twenty":-2.816561,"median":-2.297739,"eighty":-1.703553,"marketCap":51825505},{"date":"2025-08-01","current":-2.414808,"twenty":-2.814712,"median":-2.307355,"eighty":-1.704922,"marketCap":47582481},{"date":"2025-08-08","current":-2.276379,"twenty":-2.814253,"median":-2.307364,"eighty":-1.709911,"marketCap":44854823},{"date":"2025-08-15","current":-3.182597,"twenty":-2.827663,"median":-2.314914,"eighty":-1.7146,"marketCap":51469423},{"date":"2025-08-22","current":-3.121393,"twenty":-2.83463,"median":-2.320217,"eighty":-1.715028,"marketCap":50479626},{"date":"2025-08-29","current":-3.100992,"twenty":-2.845474,"median":-2.326175,"eighty":-1.71681,"marketCap":50149694},{"date":"2025-09-05","current":-3.039788,"twenty":-2.856962,"median":-2.332248,"eighty":-1.72061,"marketCap":49159897},{"date":"2025-09-12","current":-3.468214,"twenty":-2.877494,"median":-2.337903,"eighty":-1.72632,"marketCap":56088474},{"date":"2025-09-19","current":-3.202998,"twenty":-2.948857,"median":-2.33896,"eighty":-1.734352,"marketCap":51799355},{"date":"2025-09-26","current":-3.202998,"twenty":-2.967408,"median":-2.345739,"eighty":-1.747235,"marketCap":51799355},{"date":"2025-10-03","current":-3.672227,"twenty":-2.976985,"median":-2.34725,"eighty":-1.747235,"marketCap":59387796},{"date":"2025-10-10","current":-3.509017,"twenty":-3.007656,"median":-2.358441,"eighty":-1.748718,"marketCap":56748338},{"date":"2025-10-17","current":-2.75417,"twenty":-3.008543,"median":-2.366511,"eighty":-1.754778,"marketCap":44540847},{"date":"2025-10-24","current":-2.978584,"twenty":-3.007656,"median":-2.37828,"eighty":-1.756896,"marketCap":48170101},{"date":"2025-10-31","current":-2.672565,"twenty":-3.007656,"median":-2.383983,"eighty":-1.763338,"marketCap":43221118},{"date":"2025-11-07","current":-2.244139,"twenty":-3.004309,"median":-2.379435,"eighty":-1.763338,"marketCap":36292542},{"date":"2025-11-14","current":-1.674294,"twenty":-2.999223,"median":-2.377326,"eighty":-1.748718,"marketCap":37402630},{"date":"2025-11-21","current":-1.443871,"twenty":-2.998653,"median":-2.366294,"eighty":-1.72632,"marketCap":32255139},{"date":"2025-11-28","current":-1.956106,"twenty":-2.997323,"median":-2.358441,"eighty":-1.721124,"marketCap":43698122},{"date":"2025-12-05","current":-1.98926,"twenty":-2.978584,"median":-2.34725,"eighty":-1.724025,"marketCap":44438768},{"date":"2025-12-12","current":-2.718655,"twenty":-2.977224,"median":-2.346358,"eighty":-1.725117,"marketCap":60732983},{"date":"2025-12-19","current":-1.98926,"twenty":-2.976027,"median":-2.341497,"eighty":-1.731131,"marketCap":44438768},{"date":"2025-12-26","current":-2.45342,"twenty":-2.973743,"median":-2.341497,"eighty":-1.744014,"marketCap":54807814},{"date":"2026-01-02","current":-2.620787,"twenty":-2.970455,"median":-2.345739,"eighty":-1.747235,"marketCap":58546666},{"date":"2026-01-09","current":-2.843468,"twenty":-2.96857,"median":-2.347113,"eighty":-1.747235,"marketCap":63521219},{"date":"2026-01-16","current":-2.723563,"twenty":-2.965179,"median":-2.358441,"eighty":-1.751685,"marketCap":60842614},{"date":"2026-01-23","current":-4.111038,"twenty":-2.974885,"median":-2.366078,"eighty":-1.754905,"marketCap":91837908},{"date":"2026-01-30","current":-4.093909,"twenty":-2.990595,"median":-2.371936,"eighty":-1.758507,"marketCap":91455250},{"date":"2026-02-06","current":-3.271701,"twenty":-3.007134,"median":-2.379234,"eighty":-1.763338,"marketCap":73087668},{"date":"2026-02-13","current":-3.374477,"twenty":-3.016174,"median":-2.383983,"eighty":-1.763338,"marketCap":75383616},{"date":"2026-02-20","current":-3.5629,"twenty":-3.030889,"median":-2.383983,"eighty":-1.763338,"marketCap":79592853},{"date":"2026-02-27","current":-3.734193,"twenty":-3.039712,"median":-2.385818,"eighty":-1.763338,"marketCap":83419433},{"date":"2026-03-06","current":-4.017537,"twenty":-3.049862,"median":-2.392568,"eighty":-1.764948,"marketCap":89749155},{"date":"2026-03-13","current":-4.122571,"twenty":-3.060189,"median":-2.396586,"eighty":-1.771567,"marketCap":92095539},{"date":"2026-03-20","current":-3.938762,"twenty":-3.06481,"median":-2.399999,"eighty":-1.772274,"marketCap":87989368},{"date":"2026-03-27","current":-3.738436,"twenty":-3.077322,"median":-2.403689,"eighty":-1.772274,"marketCap":83726657},{"date":"2026-04-02","current":-3.630076,"twenty":-3.091579,"median":-2.414792,"eighty":-1.772274,"marketCap":81299797},{"date":"2026-04-10","current":-3.250814,"twenty":-3.101567,"median":-2.416424,"eighty":-1.779027,"marketCap":72805789},{"date":"2026-04-17","current":-3.602986,"twenty":-3.12045,"median":-2.426555,"eighty":-1.779027,"marketCap":80693083},{"date":"2026-04-24","current":-3.413355,"twenty":-3.138859,"median":-2.429844,"eighty":-1.779442,"marketCap":76446078},{"date":"2026-05-01","current":-3.602986,"twenty":-3.141794,"median":-2.430189,"eighty":-1.779442,"marketCap":80693083},{"date":"2026-05-08","current":-3.548805,"twenty":-3.151902,"median":-2.436946,"eighty":-1.787358,"marketCap":79479653},{"date":"2026-05-15","current":-3.402809,"twenty":-3.160645,"median":-2.440654,"eighty":-1.787494,"marketCap":82513227},{"date":"2026-05-22","current":-3.209467,"twenty":-3.162196,"median":-2.449568,"eighty":-1.794899,"marketCap":77824970},{"date":"2026-05-29","current":-3.234541,"twenty":-3.168124,"median":-2.452752,"eighty":-1.795416,"marketCap":78432977},{"date":"2026-06-05","current":-3.761094,"twenty":-3.186677,"median":-2.454213,"eighty":-1.795545,"marketCap":91201137},{"date":"2026-06-12","current":-3.259615,"twenty":-3.202998,"median":-2.458233,"eighty":-1.795545,"marketCap":79040985},{"date":"2026-06-18","current":-3.309763,"twenty":-3.20429,"median":-2.459855,"eighty":-1.798573,"marketCap":80257000},{"date":"2026-06-26","current":-3.384985,"twenty":-3.219198,"median":-2.466904,"eighty":-1.800591,"marketCap":82081023},{"date":"2026-07-02","current":-3.585576,"twenty":-3.223399,"median":-2.468445,"eighty":-1.800591,"marketCap":86945083},{"date":"2026-07-10","current":-3.660798,"twenty":-3.234541,"median":-2.478676,"eighty":-1.801793,"marketCap":88769106},{"date":"2026-07-17","current":-3.334837,"twenty":-3.243235,"median":-2.481254,"eighty":-1.808221,"marketCap":80865008},{"date":"2026-07-24","current":-3.209467,"twenty":-3.247477,"median":-2.487249,"eighty":-1.816839,"marketCap":77824970},{"date":"2026-07-31","current":-3.134245,"twenty":-3.243801,"median":-2.489247,"eighty":-1.819431,"marketCap":76000947},{"date":"2026-08-07","current":-3.560502,"twenty":-3.250814,"median":-2.49489,"eighty":-1.820809,"marketCap":86337076},{"date":"2026-08-14","current":-3.034921,"twenty":-3.250814,"median":-2.499534,"eighty":-1.82524,"marketCap":81473015},{"date":"2026-08-21","current":-3.126805,"twenty":-3.250637,"median":-2.503408,"eighty":-1.825742,"marketCap":83939664}],"updateTime":1787635168544},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MAIA\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2662063862","title":"Maia Biotechnology Director Ramiro Guerrero Reports Purchase of 11,899 Common Shares for $16,301.63","url":"https://stock-news.laohu8.com/highlight/detail?id=2662063862","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":1,"itemType":null,"share":"https://ttm.financial/m/news/2662063862?lang=en_us&edition=fundamental","pubTime":"2026-08-25 04:10","pubTimestamp":1787602240,"startTime":"0","endTime":"0","summary":"Maia Biotechnology director Ramiro Guerrero reports purchase of 11,899 common shares for $16,301.63Maia Biotechnology director Ramiro Guerrero bought 11,899 common shares in open-market purchases at U","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nNDL4q7JKZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Maia Biotechnology Director Ramiro Guerrero Reports Purchase of 11,899 Common Shares for $16,301.63","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MAIA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661229712","title":"MAIA Biotechnology files $150M mixed securities shelf","url":"https://stock-news.laohu8.com/highlight/detail?id=2661229712","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661229712?lang=en_us&edition=fundamental","pubTime":"2026-08-22 04:20","pubTimestamp":1787343608,"startTime":"0","endTime":"0","summary":"16:17 EDT MAIA Biotechnology (MAIA) files $150M mixed securities shelf Published first on TheFly – the ultimate source for real-time, market-moving...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/maia-biotechnology-files-150m-mixed-securities-shelf-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/maia-biotechnology-files-150m-mixed-securities-shelf-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MAIA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658931393","title":"MAIA Biotechnology Q2 EPS $(0.13) Misses $(0.11) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2658931393","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658931393?lang=en_us&edition=fundamental","pubTime":"2026-08-10 21:06","pubTimestamp":1786367179,"startTime":"0","endTime":"0","summary":"MAIA Biotechnology (AMEX:MAIA) reported quarterly losses of $(0.13) per share which missed the analyst consensus estimate of $(0.11) by 18.18 percent. This is a 27.78 percent increase over losses of $(0.18) per share","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/08/61073843/maia-biotechnology-q2-eps-0-13-misses-0-11-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MAIA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658193906","title":"Maia Biotech Q2 FY26 Net Loss Widens 49% to $7.94 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2658193906","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658193906?lang=en_us&edition=fundamental","pubTime":"2026-08-10 21:02","pubTimestamp":1786366976,"startTime":"0","endTime":"0","summary":"Maia Biotech Q2 FY26 net loss widens 49% to $7.94 millionMaia Biotechnology posted a net loss of $7.94 million in Q2 2026, widening 49% from a year earlier.Operating loss widened 61% to $8.32 million ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nNDLbh97S9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MAIA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650979881","title":"Noble Financial Sticks to Their Buy Rating for MAIA Biotechnology, Inc. (MAIA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2650979881","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650979881?lang=en_us&edition=fundamental","pubTime":"2026-07-10 01:45","pubTimestamp":1783619124,"startTime":"0","endTime":"0","summary":"In a report released today, Robert LeBoyer from Noble Financial reiterated a Buy rating on MAIA Biotechnology, Inc., with a price target of $14.00....","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/noble-financial-sticks-to-their-buy-rating-for-maia-biotechnology-inc-maia-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/noble-financial-sticks-to-their-buy-rating-for-maia-biotechnology-inc-maia-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NBL","MAIA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649947429","title":"Maia Biotechnology Says Ateganosine Plus Cemiplimab Outperforms Standard Chemotherapy Dcr in 3l Nsclc","url":"https://stock-news.laohu8.com/highlight/detail?id=2649947429","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649947429?lang=en_us&edition=fundamental","pubTime":"2026-07-08 22:49","pubTimestamp":1783522190,"startTime":"0","endTime":"0","summary":"July 8 (Reuters) - Maia Biotechnology Inc::*MAIA BIOTECHNOLOGY REPORTS STRONG INITIAL EFFICACY DATA IN THIRD-LINE NON-SMALL CELL LUNG CANCER FROM PHASE 2 THIO-101 PART C EXPANSION TRIAL*MAIA BIOTECHNO","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260708:nRSD7qCsFh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MAIA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649619991","title":"MAIA Biotechnology reports efficacy data from Phase 2 THIO-101 Part C expansion","url":"https://stock-news.laohu8.com/highlight/detail?id=2649619991","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649619991?lang=en_us&edition=fundamental","pubTime":"2026-07-08 21:50","pubTimestamp":1783518622,"startTime":"0","endTime":"0","summary":"MAIA Biotechnology (MAIA) announced initial efficacy data from its Phase 2 THIO-101 clinical trial expansion, Part C, evaluating its lead candidate...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/maia-biotechnology-reports-efficacy-data-from-phase-2-thio-101-part-c-expansion-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/maia-biotechnology-reports-efficacy-data-from-phase-2-thio-101-part-c-expansion-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IDNA","MEDX","MAIA","GDOC","HYLG","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649999043","title":"Maia Biotech Reports 90.5% Disease Control Rate in Phase 2 Third-line NSCLC Trial Expansion","url":"https://stock-news.laohu8.com/highlight/detail?id=2649999043","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649999043?lang=en_us&edition=fundamental","pubTime":"2026-07-08 21:45","pubTimestamp":1783518318,"startTime":"0","endTime":"0","summary":"Maia Biotech reports 90.5% disease control rate in Phase 2 third-line NSCLC trial expansionMaia Biotechnology reported a 90.5% interim disease control rate in Phase 2 THIO-101 Part C for third-line ad","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260708:nNDL19MYzw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BCDF","BK4588","SG9999014039.USD","IE00BN0W2W23.USD","IE00BGHQF748.EUR","MAIA","IE00B64PRP62.GBP","IE00BN0W2T93.GBP","SG9999014013.SGD","SG9999014021.USD","BK4112","IE00BN0W2V16.EUR","LU2210149790.SGD","IE00BKPKM429.USD","NDAQ","LU2210150020.SGD","BK4139","LU2095319765.USD","SG9999014005.SGD","BK4585","IE00B3QW5Z07.USD","LU0314104364.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649999064","title":"Maia Biotechnology - Ateganosine Plus Cemiplimab Shows Acceptable Safety Profile in Heavily Pre-treated Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2649999064","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649999064?lang=en_us&edition=fundamental","pubTime":"2026-07-08 21:45","pubTimestamp":1783518300,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260708:nTUAQ7RJ8:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MAIA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649990619","title":"Maia Biotechnology Reports Strong Initial Efficacy Data in Third-line Non-small Cell Lung Cancer from Phase 2 Thio-101 Part C Expansion Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2649990619","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649990619?lang=en_us&edition=fundamental","pubTime":"2026-07-08 21:45","pubTimestamp":1783518300,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260708:nTUAQ7RJ8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MAIA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649799906","title":"Maia Biotechnology - Thio-101 Part C Shows 90.5% Disease Control Rate in 3L Nsclc","url":"https://stock-news.laohu8.com/highlight/detail?id=2649799906","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649799906?lang=en_us&edition=fundamental","pubTime":"2026-07-08 21:45","pubTimestamp":1783518300,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260708:nTUAQ7RJ8:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MAIA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649062999","title":"Maia Biotechnology - Ateganosine Plus Cemiplimab Outperforms Standard Chemotherapy Dcr in 3L Nsclc","url":"https://stock-news.laohu8.com/highlight/detail?id=2649062999","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649062999?lang=en_us&edition=fundamental","pubTime":"2026-07-08 21:45","pubTimestamp":1783518300,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260708:nTUAQ7RJ8:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","MAIA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646605870","title":"Maia Biotechnology Completes International Enrollment in Part C of Phase 2 Thio-101 Expansion Trial in Third-line Non-small Cell Lung Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2646605870","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646605870?lang=en_us&edition=fundamental","pubTime":"2026-06-25 20:08","pubTimestamp":1782389280,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260625:nTUA5MLKGH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MAIA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646870966","title":"MAIA Biotechnology Completes International Enrollment in Part C of Phase 2 THIO-101 Expansion Trial in Third-Line Non-Small Cell Lung Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2646870966","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646870966?lang=en_us&edition=fundamental","pubTime":"2026-06-25 20:08","pubTimestamp":1782389280,"startTime":"0","endTime":"0","summary":"Part C domestic enrollment is underway at three clinical sites in the U.S. CHICAGO, June  25, 2026  (GLOBE NEWSWIRE) -- MAIA Biotechnology, Inc. (NYSE American: MAIA) (“MAIA”, the “Company”), a clinic","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/06/25/3317503/0/en/MAIA-Biotechnology-Completes-International-Enrollment-in-Part-C-of-Phase-2-THIO-101-Expansion-Trial-in-Third-Line-Non-Small-Cell-Lung-Cancer.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ORR","L","MAIA","CPI","BK4588","BK4585","BK4107","LU2487616109.SGD","LU0053666078.USD","BK4139","LU0210528500.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644810085","title":"Maia Biotech opens enrollment at Emory Winship for Phase 2 ateganosine NSCLC trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2644810085","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644810085?lang=en_us&edition=fundamental","pubTime":"2026-06-18 20:31","pubTimestamp":1781785888,"startTime":"0","endTime":"0","summary":"Maia Biotechnology opened enrollment at Emory University’s Winship Cancer Institute for its Phase 2 THIO-101 expansion trial in third-line NSCLC.The study evaluates ateganosine, a telomere-targeting agent, followed by cemiplimab in patients resistant to checkpoint inhibitors and chemotherapy.Early results from Parts A and B have already been presented, showing encouraging clinical benefit in some patients.The U.S. expansion adds a third domestic site, supporting broader recruitment for a setting with no FDA-approved third-line options.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260618:nNDLbNrbBV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","SG9999014013.SGD","NDAQ","MAIA","IE00B64PRP62.GBP","LU2210150020.SGD","SG9999014021.USD","IE00BKPKM429.USD","BK4139","IE00B3QW5Z07.USD","LU2210149790.SGD","IE00BN0W2W23.USD","SG9999014005.SGD","LU2095319765.USD","IE00BN0W2T93.GBP","IE00BN0W2V16.EUR","BK4112","SG9999014039.USD","IE00BGHQF748.EUR","LU0314104364.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644808302","title":"Maia Biotechnology Opens Enrollment for Phase 2 Expansion Trial of Novel Telomere-Targeting Agent at Winship Cancer Institute of Emory University","url":"https://stock-news.laohu8.com/highlight/detail?id=2644808302","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644808302?lang=en_us&edition=fundamental","pubTime":"2026-06-18 20:30","pubTimestamp":1781785800,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260618:nTUABM17DY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","MAIA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1167022508","title":"Compugen to Unveil Latest Data from MAIA Ovarian Cancer Drug Trial at European Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=1167022508","media":"Deep News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1167022508?lang=en_us&edition=fundamental","pubTime":"2026-06-11 23:20","pubTimestamp":1781191233,"startTime":"0","endTime":"0","summary":"Clinical-stage cancer immunotherapy company Compugen Ltd. announced on Thursday that it will present the latest progress from its MAIA-ovarian trial in a poster presentation at the 2026 European...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MAIA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642442946","title":"Maia Biotech opens enrollment at second US site for Phase 2 THIO-101 lung cancer trial expansion","url":"https://stock-news.laohu8.com/highlight/detail?id=2642442946","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642442946?lang=en_us&edition=fundamental","pubTime":"2026-06-10 21:20","pubTimestamp":1781097631,"startTime":"0","endTime":"0","summary":"Maia Biotechnology opened enrollment at a second US site for its Phase 2 THIO-101 expansion trial in third-line non-small cell lung cancer.No new results were presented; additional expansion data are expected in future interim updates to support a potential FDA accelerated approval filing.The study evaluates ateganosine in patients who failed checkpoint inhibitors and chemotherapy, aiming to show clinically meaningful benefit without detailing metrics.Maia is also screening patients for a pivotal Phase 3 overall-survival study comparing ateganosine sequenced with a CPI versus investigator’s-choice chemotherapy.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Maia Biotechnology Inc. published the original content used to generate this ne","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260610:nNDL6MN2LH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MAIA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642542915","title":"Maia Biotechnology Activates and Opens Enrollment at Second U.S. Clinical Site for International Phase 2 Thio-101 Expansion Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2642542915","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642542915?lang=en_us&edition=fundamental","pubTime":"2026-06-10 21:15","pubTimestamp":1781097300,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260610:nTUA2X2ZSG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MAIA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642209429","title":"MAIA Biotechnology Activates and Opens Enrollment at Second U.S. Clinical Site for International Phase 2 THIO-101 Expansion Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2642209429","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642209429?lang=en_us&edition=fundamental","pubTime":"2026-06-10 21:15","pubTimestamp":1781097300,"startTime":"0","endTime":"0","summary":"Additional data from MAIA’s THIO-101 expansion may further support an accelerated approval filing with the FDA Potential breakthrough therapy holds substantial commercial opportunity in a projected $7","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/06/10/3309785/0/en/MAIA-Biotechnology-Activates-and-Opens-Enrollment-at-Second-U-S-Clinical-Site-for-International-Phase-2-THIO-101-Expansion-Trial.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","L","CPI","BK4139","LU2487616109.SGD","LU0053666078.USD","LU0210528500.USD","MAIA","BK4585","BK4081","EMA","BK4107","ORR"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":1,"totalSize":65,"code":"91000000","status":"200"}]}}